Latest news

Epigenica Receives Substantial Backing from Almi Invest

Almi Invest has made a significant investment in the company Epigenica early in the fall. The company is focused on advancing epigenomics by delivering state-of-the-art epigenetic screening tools. With its multiplexing technology, the company offers its customers more comprehensive information faster, at a fraction of the cost they currently pay for the same knowledge.

Read More »

This website uses cookies. By continuing to use this site, you accept our use of cookies.